Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(3-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE, also known as APDIQ, is a chemical compound that belongs to the aryl ketone family. It features an aminophenyl and dihydroquinolinyl moiety attached to the carbonyl group, which contributes to its potential pharmacological significance.
Used in Pharmaceutical Industry:
APDIQ is used as a psychoactive drug for its potential recreational use and abuse. It has been studied for its effects on the central nervous system, which may lead to its use in the development of therapeutic agents for various medical conditions.
Used in Neurodegenerative Disorders Research:
In the field of neurodegenerative disorders, APDIQ is used as a research compound to investigate its potential as a therapeutic agent. Its pharmacological properties may offer insights into the treatment and management of such conditions.
Used in Psychiatric Disorders Research:
APDIQ is also used in psychiatric research to explore its potential as a therapeutic agent for various psychiatric disorders. Its psychoactive properties may contribute to the development of new treatments for mental health conditions.
Used in Law Enforcement and Regulatory Agencies:
Due to its psychoactive properties and potential for abuse, APDIQ is of interest to law enforcement and regulatory agencies. It is used as a subject of legal restrictions and monitoring in many jurisdictions to prevent misuse and ensure public safety.

137975-41-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 137975-41-8 Structure
  • Basic information

    1. Product Name: (3-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE
    2. Synonyms: (3-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE;3-(1,2,3,4-tetrahydroquinoline-1-carbonyl)aniline;(3-aminophenyl)(3,4-dihydroquinolin-1(2H)-yl)methanone
    3. CAS NO:137975-41-8
    4. Molecular Formula: C16H16N2O
    5. Molecular Weight: 252.31104
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 137975-41-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: (3-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE(CAS DataBase Reference)
    10. NIST Chemistry Reference: (3-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE(137975-41-8)
    11. EPA Substance Registry System: (3-AMINOPHENYL)[3,4-DIHYDRO-1(2H)-QUINOLINYL]-METHANONE(137975-41-8)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 137975-41-8(Hazardous Substances Data)

137975-41-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 137975-41-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,7,9,7 and 5 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 137975-41:
(8*1)+(7*3)+(6*7)+(5*9)+(4*7)+(3*5)+(2*4)+(1*1)=168
168 % 10 = 8
So 137975-41-8 is a valid CAS Registry Number.

137975-41-8Downstream Products

137975-41-8Relevant articles and documents

Orally active, nonpeptide vasopressin V2 receptor antagonists: A novel series of 1-[4-(benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and related compounds

Ogawa, Hidenori,Yamashita, Hiroshi,Kondo, Kazumi,Yamamura, Yoshitaka,Miyamoto, Hisashi,Kan, Keizo,Kitano, Kazuyoshi,Tanaka, Michinori,Nakaya, Kenji,Nakamura, Shigeki,Mori, Toyoki,Tominaga, Michiaki,Yabuuchi, Youichi

, p. 3547 - 3555 (2007/10/03)

This paper describes a novel series of nonpeptide vasopressin V2 receptor antagonists. It has been demonstrated that the 1-[4- (benzoylamino)benzoyl]-2,3,4,5-1H-benzazepines and 1-[4- (benzoylamino)benzoyl]-2,3,4,5-1H-1,5-benzodiazepines show a high affinity for V2 (and V(1a)) receptors. Among the 1-[4-(benzoylamino)benzoyl]-2,3,4,5- 1H-benzazepine series, compounds with an alkylamino group on the benzazepine ring have been shown to have oral activity. A lipophilic group at the ortho position on the terminal benzoyl ring is important for both high V2 receptor affinity and oral activity. On the basis of these favorable properties, clinical testing of 31b has begun for use as an oral and iv aquaretic agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 137975-41-8